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Background: Various findings suggest that uric acid is an inflammatory factor and may have a role in endothelial dysfunction 
and act as a mediator of diabetic nephropathy. The objective of this study was to evaluate the relationships between serum uric 
acid level and level of proteinuria in type 2 diabetic (T2D) patients. Materials and Methods: A cross‑sectional analytical study 
was conducted in 60 patients with T2D without a history of gout. None was treated with allopurinol. Venous blood samples were 
obtained in fasting state for determinations of serum creatinine, uric acid, and hemoglobin A1c (HbA1c) (reference range 3.8‑5.5%); 
24‑h urine proteinuria was also measured. Results: Mean age of the patients was 57 ± 8.3 years. Mean ± standard error (SE) of 
serum creatinine was 0.98 ± 0.028 mg/dL, mean ± SE of serum uric acid was 4.5 ± 0.15 mg/dL, and mean ± SE of proteinuria was 
388 ± 28.7 mg/day (median = 303.5 mg/day). There was no significant difference in serum uric acid, HbA1c, and creatinine level 
between males and females (P > 0.05). There was a significant positive association between body mass index (BMI) and serum uric acid 
levels (r = 0.428, P = 0.001). After adjustment for weight, a significant positive association of serum uric acid with level of proteinuria 
was seen (r = 0.47, P < 0.001). Conclusion: Serum uric acid had a significant positive association with diabetic nephropathy. It might 
be hypothesized that serum uric acid plays a role in diabetic nephropathy in T2D.
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hemoglobin A1c (HbA1c) (reference range 3.8‑5.5%); 24‑h 
urine proteinuria was also measured.
Results were expressed as mean ± standard deviation (SD) 
and were considered as statistically significant when 
two‑sided P  < 0.05. Independent‑samples t‑test was 
used for comparison variables between male and female. 
Spearman’s rho coefficient correlation test was used 
for correlation of BMI with serum uric acid and partial 
correlation coefficient test was used for correlation of 
protenuria with serum uric acid.
RESULTS
A total of 60 T2D patients were enrolled in the 
study (56.7% female, age range: 41‑81 years, mean 
age: 57  ± 8.3 years). Mean  ± SE of serum creatinine 
was 0.98 ± 0.028 mg/dL, mean ± SE of serum uric acid 
was 4.5  ± 0.15 mg/dL, and mean  ± SE of proteinuria 
was 388 ± 28.7 mg/day (median = 303.5 mg/day). The 
results of interested variable are shown in Table 1. In this 
study, there was no significant difference of serum uric 
acid, HbA1c, and creatinine between males and females 
(P > 0.05). There was a significant positive association 
between BMI and serum uric acid (r = 0.428, P = 0.001). 
After adjustment for weight, a significant positive 
association of serum uric acid level with proteinuria 
level was seen (r = 0.47, P < 0.001).
INTRODUCTION
Despite advances in the care of patients with diabetes, 
diabetic nephropathy (DN) remains the most common 
etiology for end‑stage.[1‑5] Various factors have been 
associated with the development of DN in type 2 
diabetic (T2D) patients, including age, poor glycemic 
control, hypertension, and smoking.[2‑10] Of them, 
inflammation and endothelial dysfunction seems to play 
a basic role in the development of DN. Recent findings 
suggest that uric acid is an inflammatory factor, may 
have a role in endothelial dysfunction,[9‑13] and act as a 
mediator of DN.[10‑14] The objective of this study was to 
find an association between serum uric acid level and 
proteinuria level in T2D patients.
MATERIALS AND METHODS
A cross‑sectional analytical study was conducted in 2011 
on 60 patients (both genders, age range 41‑81 years) with 
T2D. The patients’ body weight was stable for at least 
3 months before the study. None of the patients had a 
history of gout and none was treated with allopurinol. 
Body mass index (BMI) was calculated in kg/m2.[10,15‑17] 
Patients’ history, current medications, insulin doses, 
tobacco use, and family medical history were obtained. 
Venous blood samples were obtained in fasting state 
for determinations of serum creatinine, uric acid, and 
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DISCUSSION
The etiology of DN is complex and remains to be clarified.[2,4] 
Presently, diabetes is the leading cause of end‑stage renal 
disease in the most parts of the world.[2‑5,14,18‑23] Although 
the progression of kidney disease can be halted partially, 
DN is still regarded as an irreversible and progressive 
disease.[2‑5,14,18‑24] Thus, it has become increasingly essential 
to find the pathophysiological mechanisms that leads 
to the development and progression of DN.[24‑26] In this 
study, we found the significant positive association of 
serum uric acid with level of proteinuria, when adjusted 
for weight. Hyperuricemia and its association with obesity 
and various components of metabolic syndrome have been 
documented in previous studies.[24,25] Hyperuricemia is also 
prevalent in patients with chronic renal failure.[23‑29] Indeed, 
various studies have shown that hyperuricemia may have 
a pathogenic role in the development and progression of 
chronic renal failure, rather than simply reflecting decreased 
renal uric acid excretion.[24‑27] In diabetic patients, serum uric 
acid early in the course of diabetes is significantly associated 
with later development of persistent macroalbuminuria.[26‑28] 
It was shown that kidney damage in hyperuricemic rats 
is not dependent on blood pressure and instead involves 
the renin–angiotensin system (RAS).[25‑28] An association 
between serum uric acid and early loss of renal function has 
been shown in patients with type 1 diabetes.[27‑29] In the study 
conducted by Fukui et al., positive correlation of serum uric 
acid and urinary albumin excretion in 343 men with type 2 
diabetes mellitus was shown.[30] They concluded that serum 
uric acid concentration is associated with microalbuminuria 
and subclinical atherosclerosis in men with type 2 diabetes 
mellitus.[30] Similarly, Fu et al., in a study on Chinese diabetic 
patients, found that hyperuricemia was significantly 
associated with abnormal albuminuria in patients without 
diuretics or use of uricosuric agents or alcohol. They 
concluded that hyperuricemia were significantly related 
to the presence of albuminuria in patients with diabetes.[31] 
Elevated level of serum uric acid can lead to low‑grade 
kidney injury without deposition of uric acid crystals in 
animal models.[32] Also, hyperuricemia in rats induced 
arteriolopathy of preglomerular vessels, resulting in 
impaired autoregulation, glomerular hypertension, and 
endothelial dysfunction.[27,29] It was found that microvascular 
disease in hyperuricemic rats occurs independent of blood 
pressure and is dependent on activation of the systemic and 
local RAS and inhibition of endothelial nitric oxide.[27,29,33,34] 
In the study conducted by Obermayr et al., serum uric acid 
was found to be a predictor of new onset kidney disease, 
independent of other risk factors.[35] In conclusion, in our 
study, serum uric acid had a significant positive association 
with DN. Given this fact, we hypothesized that serum uric 
acid plays a pathological role in the development of DN in 
T2D. To approve this hypothesis, we suggest studying of 
the effect of lowering uric acid with allopurinol on renal 
function in DN patients in future.
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